KRAS and non-small cell lung carcinoma: NRAS/HRAS (Neuroblastoma/Harvey Rat Sarcoma Viral Oncogenes) Non-KRAS RAS mutations are uncommon LUAD (pan-NSCLC) drivers but clinically relevant when present.